这一程序被称为过继转移，是一种肿瘤免疫治疗策略，已经用于多种人类肿瘤的临床试验。
This procedure, referred to as adoptive transfer, is an immunotherapy strategy against cancer being tested in a number of human clinical trials.
并通过过继转移实验、外源IL-2对耐受小鼠供体特异性MLR的影响等进一步探讨耐受形成的机制。
Adoptive transfer and the effect of IL - 2 on MLR were detected to further explore the tolerance mechanism.
并通过过继转移实验、外源IL-2对耐受小鼠供体特异性MLR的影响等进一步探讨耐受形成的机制。
Adoptive transfer and the effect of IL - 2 on MLR were detected to further explore the tolerance mechanism.
应用推荐